λ””μ˜€ 둜고

λ””μ˜€ (039840) μ£Όκ°€ 및 μ’…λͺ© 정보

λ””μ˜€ μ‹€μ‹œκ°„ μ£Όκ°€

λ””μ˜€ ν˜„μž¬κ°€ 상세 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 16,030 원
λ³€λ™λŸ‰ β–Ό 60.00 원
변동λ₯  -0.37%
κ±°λž˜λŸ‰ 19,534
κ±°λž˜λŒ€κΈˆ 311,660,500 원

λ””μ˜€ 일별 μ£Όκ°€

λ””μ˜€μ˜ κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
12/28/2025 16,640 17,150 16,610 16,900 27,181 457,291,430
12/29/2025 17,150 17,150 16,770 16,890 9,164 154,519,430
1/1/2026 16,720 17,060 16,660 16,840 22,929 385,643,135
1/4/2026 16,750 16,750 16,290 16,450 31,142 512,086,725
1/5/2026 16,500 16,500 16,170 16,300 23,152 376,967,830
1/6/2026 16,350 16,410 15,770 16,110 33,806 540,045,490
1/7/2026 16,110 16,170 15,870 16,120 14,966 239,289,060
1/8/2026 16,120 16,150 15,860 16,090 22,664 362,651,850
1/11/2026 16,150 16,190 15,910 16,090 7,808 125,449,430
1/12/2026 16,400 16,400 15,830 16,030 19,534 311,660,500

κ΄€λ ¨ ν…Œλ§ˆ

  • 문재인 : κΉ€μ§„μ²  사내이사가 문재인 λŒ€ν†΅λ Ήκ³Ό 경남고 동문이며, λ¬Έμž¬μΈμΌ€μ–΄ μ •μ±…μœΌλ‘œ 노인 μž„ν”Œλž€νŠΈ 본인 λΆ€λ‹΄λ₯  삭감 κΈ°λŒ€κ°μ— μ£Όλͺ©λ°›μ€ λ°” 있음
  • μž„ν”Œλž€νŠΈ/μΉ˜μ•„ : μΈκ³΅μΉ˜μ•„μš© μž„ν”Œλž€νŠΈμ™€ 같은 의료 κΈ°κΈ°λ₯Ό 생산 및 판맀, μž„ν”Œλž€νŠΈ μ‹œμˆ  μ‹œμŠ€ν…œ μ†”λ£¨μ…˜ 기술λ ₯ λ³΄μœ ν•œ κΈ°μ—…
  • κ³ λ Ήν™”/노인볡지 : 의료 κΈ°κΈ° 및 μΈκ³΅μΉ˜μ•„μš© μž„ν”Œλž€νŠΈ μ œν’ˆμ„ 생산 및 νŒλ§€ν•˜λŠ” κΈ°μ—…

λ””μ˜€ νšŒμ‚¬ 정보

μ‹œμž₯ μ‹œκ°€μ΄μ•‘ κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅° 52μ£Ό 졜고 52μ£Ό μ΅œμ €
kosdaq 2,304μ–΅ 417μœ„ 14,375,087 13.92% ν—¬μŠ€μΌ€μ–΄ 의료μž₯λΉ„/μš©ν’ˆ 21,200 15,130

λ””μ˜€ κΈ°μ—… κ°œμš”

λ””μ˜€λŠ” 1988λ…„ 1μ›” μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ 의료기기(μΈκ³΅μΉ˜μ•„μš© μž„ν”Œλž€νŠΈ) μ œν’ˆ 생산 및 νŒλ§€μ—…μ„ μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” 쒅속기업은 DIO USA, BEIJING DIO CO.,LTD λ“±μ˜ 해외기업을 λ³΄μœ ν•˜κ³  μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ μž„ν”Œλž€νŠΈ, μΉ˜μ•½ λ“±μ˜ μ œν’ˆ 판맀둜 λ°œμƒν•˜κ³  μžˆλ‹€. κΈ€λ‘œλ²Œ μ˜λ£ŒκΈ°κΈ°μ—…κ³„ 졜초둜 λ―Έκ΅­ μ—¬μž ν”„λ‘œκ³¨ν”„ LPGA 타이틀 μŠ€ν°μ„œμ‹­μ„ 체결, "2022 DIO Implant LA Open’을 μ„±κ³΅μ μœΌλ‘œ κ°œμ΅œν•˜λ©°, λ―Έκ΅­, μΊλ‚˜λ‹€λ₯Ό ν¬ν•¨ν•˜μ—¬ κΈ€λ‘œλ²Œ μ‹œμž₯μ—μ„œμ˜ 맀좜 νŒŒκΈ‰νš¨κ³Όλ₯Ό κΈ°λŒ€ν•˜κ³  μžˆλ‹€.

λ””μ˜€ AI예츑

AIμ˜ˆμΈ‘κΈ°λŠ” λ””μ˜€μ„ κ°•λ ₯맀도 Β· 맀도 Β· 쀑립 Β· 맀수 Β· κ°•λ ₯맀수 둜 μ˜ˆμΈ‘ν–ˆμ–΄μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ μ˜ˆμƒ μ£Όκ°€ μ‹œλ‚˜λ¦¬μ˜€μ™€ AI의 투자의견, λͺ©ν‘œΒ·μ†μ ˆκ°€, AIκ°€ μ°Έκ³ ν•œ 차트 νŒ¨ν„΄λ“€μ„ 확인할 수 μžˆμŠ΅λ‹ˆλ‹€.

λ””μ˜€ μ§€ν‘œλΆ„μ„

수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ€ λ””μ˜€μ„ 맀수 Β· 맀도 Β· 보유 Β· 관망 μ€‘μ΄μ—μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ 수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ˜ λ§€λ§€ μ‹œμ μ„ ν™•μΈν•˜κ³  λ‹€μŒ μ‹ ν˜Έλ₯Ό μ•Œλ¦ΌμœΌλ‘œ λ°›μ•„λ³Ό 수 μžˆμŠ΅λ‹ˆλ‹€.

μ΅œμ‹  λ””μ˜€ κ΄€λ ¨ λ‰΄μŠ€

μ§€λ‚œ 7일 μƒν•˜μ΄ 리츠칼튼 ν˜Έν…”μ—μ„œ 산업톡상뢀가 μ£Όμž¬ν•˜λŠ” 쀑ꡭ μ§„μΆœ ν•œκ΅­κΈ°μ—… κ°„λ‹΄νšŒκ°€ κ°œμ΅œλλ‹€. 사진 제곡=λ””μ˜€κΈ€λ‘œλ²Œ μž„ν”Œλž€νŠΈ κΈ°μ—… λ””μ˜€(039840)λŠ” 이재λͺ… λŒ€ν†΅λ Ήμ˜ 쀑ꡭ 방문을 κ³„κΈ°λ‘œ μ‚°μ—…ν†΅μƒμžμ›λΆ€κ°€ μ£Όμž¬ν•œ μƒν•˜μ΄ κ°„λ‹΄νšŒμ— μ°Έμ„ν–ˆλ‹€κ³  8일 λ°ν˜”λ‹€. 관련기사 이번

λ””μ˜€(λŒ€ν‘œ 김쒅원)κ°€ 이재λͺ… λŒ€ν†΅λ Ήμ˜ 쀑ꡭ 방문을 κ³„κΈ°λ‘œ 산업톡상뢀가 μ£Όμž¬ν•œ μƒν•˜μ΄ κ°„λ‹΄νšŒμ— μ°Έμ„ν–ˆλ‹€κ³  λ°ν˜”λ‹€. 이번 κ°„λ‹΄νšŒλŠ” μ§€λ‚œ 7일 μƒν•˜μ΄ 리츠칼튼 ν˜Έν…”μ—μ„œ μ—”ν„°ν…ŒμΈλ¨ΌνŠΈ, μ˜ν™”, κ²Œμž„, ν—¬μŠ€μΌ€μ–΄, μ‹ν’ˆ, λ·°ν‹° λ“± μ†ŒλΉ„μž¬ 및 μ½˜ν…μΈ  λŒ€ν‘œκΈ°μ—… 14κ³³ 및 지원기관 3곳이 μ°Έμ—¬ν•΄ 쀑ꡭ μ§„μΆœ κΈ°μ—…μ˜ μ£Όμš”ν˜„μ•ˆκ³Ό μ• λ‘œμ‚¬ν•­, 그리고 ν–₯ν›„ 지원 μ „λž΅μ— λŒ€ν•΄ λ…Όμ˜ν–ˆλ‹€. 쀑ꡭ에 μ§„μΆœν•΄ μžˆλŠ” λŒ€ν‘œκΈ°μ—…μΈ μ•„λͺ¨λ ˆνΌμ‹œν”½, 농심, LGμƒν™œκ±΄κ°• λ“±κ³Ό ν•¨κ»˜ μž„ν”Œλž€νŠΈ 업계λ₯Ό λŒ€ν‘œν•΄μ„œλŠ” λ””μ˜€κ°€ μ°Έμ„ν–ˆλ‹€. λ””μ˜€λŠ” 이 μžλ¦¬μ—μ„œ μ€‘κ΅­μ—μ„œ μ‹ μ œν’ˆμ„ μΆœμ‹œν•˜λŠ” 과정에 λŒ€ν•œ

[νŒŒμ΄λ‚Έμ…œλ‰΄μŠ€]Β λ””μ§€ν„Έ μž„ν”Œλž€νŠΈ μ „λ¬ΈκΈ°μ—… μ£Όμ‹νšŒμ‚¬ λ””μ˜€(KOSDAQ 039840)의 μ‹ μ œν’ˆ β€˜UniCon(μœ λ‹ˆμ½˜)’이 포λ₯΄νˆ¬κ°ˆμ„ λΉ„λ‘―ν•œ 유럽 μ‹œμž₯에 본격적으둜 μ§„μΆœν–ˆλ‹€. λ””μ˜€λŠ” 졜근 μœ λŸ½μ—°ν•©(EU)μœΌλ‘œλΆ€ν„° μ‹ μ œν’ˆ UniCon에 λŒ€ν•œ MDR(Medical Device Regulation) 인증을 νšλ“ν–ˆλ‹€κ³  17일 λ°ν˜”λ‹€. 이 μ‹ μ œν’ˆμ€ μž„ν”Œλž€νŠΈ μ‹œμˆ  νŽΈμ˜μ„±μ„ κ·ΉλŒ€ν™”ν•œ λ””μ§€ν„Έ 치료 μ‹œμŠ€ν…œμ΄λ‹€. μž„ν”Œλž€νŠΈ ν”½μŠ€μ²˜μ™€ 상뢀 ꡬ쑰 κ²°ν•©λΆ€ λΆ€λΆ„ μ΅œμƒμ˜ 각도라 λΆˆλ¦¬λŠ” 11도 컀λ„₯μ…˜μ„ μ •λ°€ν•˜κ²Œ κ΅¬ν˜„ν•˜λ©° μ‹œμˆ  편의뿐 μ•„λ‹ˆλΌ μž₯기적 μ•ˆμ •μ„±κΉŒμ§€ ν™•λ³΄ν–ˆλ‹€. MDR 인증은 미ꡭ의 FDA 인증 μ΄μƒμœΌλ‘œ 세계 μ£Όμš” 인증기관과 μ‚°μ—… μ‹œμž₯의 신뒰도λ₯Ό λ°›κ³  μžˆλŠ” κ²ƒμœΌλ‘œλ„ 잘 μ•Œλ €μ Έ μžˆλ‹€. 졜근 μ•„μ‹œμ•„μ™€ 쀑동, 아프리카 λ“± ν•΄μ™Έ 각지 바이어와 λ”œλŸ¬μ‚¬λ“€μ€ μ œν’ˆ 선택 μ‹œ MDR 인증 μ—¬λΆ€λ₯Ό 1μ°¨ ν•„ν„°λ‘œ μ‚ΌλŠ” κ²½μš°λ„ λ§Žμ€ κ²ƒμœΌλ‘œ μ „ν•΄μ§„λ‹€

[μΈν¬μŠ€νƒλ°μΌλ¦¬=κΉ€λ¬Έμ˜ 기자] ν•˜λ‚˜μ¦κΆŒμ€ 16일 λ””μ˜€μ— λŒ€ν•΄ κΈ€λ‘œλ²Œ μ „λž΅μ‹œμž₯ μ€‘μ‹¬μ˜ 맀좜 회볡과 ꡬ쑰쑰정 효과둜 싀적과 μž¬λ¬΄κ΅¬μ‘°κ°€ λ™μ‹œμ— κ°œμ„  ꡭ면에 μ§„μž…ν–ˆλ‹€κ³  λ°ν˜”λ‹€. 투자의견과 λͺ©ν‘œμ£Όκ°€λŠ” μ œμ‹œν•˜μ§€ μ•Šμ•˜λ‹€.ν•œμœ κ±΄ ν•˜λ‚˜μ¦κΆŒ 연ꡬ원은 3λΆ„κΈ° 싀적과 κ΄€λ ¨ν•΄ β€œ3λΆ„κΈ° λ””μ˜€λŠ” λ§€μΆœμ•‘ μ•½ 414얡원(YoY+32.2%), μ˜μ—…μ΄μ΅ 41μ–΅6000λ§Œμ›(YoY+866.6%)을 κΈ°λ‘ν•˜λ©° 2뢄기에 이어 연속 μ„±μž₯을 이어갔닀”며 μ΄λŠ” β€œμ€‘κ΅­, 쀑동, CIS μ§€μ—­ μ€‘μ‹¬μ˜ κ°€νŒŒλ₯Έ μ„±μž₯세에 κΈ°μΈν•œ 것”이라고 μ„€λͺ…ν–ˆλ‹€.ν•œ 연ꡬ원은 쀑ꡭ μ‹œμž₯κ³Ό κ΄€λ ¨ν•΄ β€œμ€‘κ΅­ν–₯으

λ””μ˜€ 맀좜 정보

λ‚ μ§œ λ§€μΆœμ•‘ λ§€μΆœμ•‘ μ¦κ°€μœ¨ μ˜μ—…μ΄μ΅ μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨ 순이읡 순이읡 μ¦κ°€μœ¨
2024.4Q 119,649,873,058 -23.21% -40,735,380,810 -294.94% -41,320,154,654 -1677.68%
2023.4Q 155,817,892,643 18.67% 20,896,358,522 574.34% 2,619,040,355 113.03%
2022.4Q 131,306,350,000 -12.48% -4,405,389,000 -112.66% -20,107,715,000 -171.50%
2021.4Q 150,037,230,000 24.97% 34,800,124,000 15.97% 28,121,156,000 146.63%

μˆœλ§€μˆ˜λŸ‰

개인: 8,454

κΈ°κ΄€: -5,071

외인: -3,103

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: 11,770

κΈ°κ΄€: -27,334

외인: 47,136

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-01-13 8,454 -5,071 -3,103
2026-01-12 414 12 503
2026-01-09 -3,210 129 2,236
2026-01-08 3,795 5 -3,572
2026-01-07 8,229 4 -10,298
2026-01-06 9,495 110 -10,277
2026-01-05 15,110 -18 -14,338
2026-01-02 -4,419 -1,270 9,711
2025-12-30 2,485 -21 -2,737
2025-12-29 -1,332 -115 8,262
2025-12-26 4,698 7 -797
2025-12-24 1,927 -1,481 -3,291
2025-12-23 14,498 347 -11,160
2025-12-22 5,651 -29 -3,830
2025-12-19 1,590 -282 6,524
2025-12-18 3,995 -1,039 -4,315
2025-12-17 1,400 1,413 -1,130
2025-12-16 687 750 -626
2025-12-15 3,344 -363 -2,981
2025-12-12 -2,321 -1,246 3,546
2025-12-11 -13,140 561 12,641

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-01-13 61,350 -7,597 -29,032
2026-01-12 52,896 -2,526 -25,929
2026-01-09 52,482 -2,538 -26,432
2026-01-08 55,692 -2,667 -28,668
2026-01-07 51,897 -2,672 -25,096
2026-01-06 43,668 -2,676 -14,798
2026-01-05 34,173 -2,786 -4,521
2026-01-02 19,063 -2,768 9,817
2025-12-30 23,482 -1,498 106
2025-12-29 20,997 -1,477 2,843
2025-12-26 22,329 -1,362 -5,419
2025-12-24 17,631 -1,369 -4,622
2025-12-23 15,704 112 -1,331
2025-12-22 1,206 -235 9,829
2025-12-19 -4,445 -206 13,659
2025-12-18 -6,035 76 7,135
2025-12-17 -10,030 1,115 11,450
2025-12-16 -11,430 -298 12,580
2025-12-15 -12,117 -1,048 13,206
2025-12-12 -15,461 -685 16,187
2025-12-11 -13,140 561 12,641

λ””μ˜€ μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
332,330,642,380 41.39% 58.61%

λ””μ˜€ 맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
μž„ν”Œλž€νŠΈ, μΉ˜μ•½ [의료기기 μ œν’ˆ] 88.6%
μ˜λ£ŒκΈ°κΈ°μ™Έ [의료기기 μƒν’ˆ] 11.4%

λ””μ˜€ 곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 1,275 (4.83%)

졜근 곡맀도 μž”κ³ : 49,168 (0.34%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2026-01-13 16,030 1,275 4.83%
2026-01-12 16,090 117 1.04%
2026-01-09 16,090 427 1.25%
2026-01-08 16,120 1,791 8.16%
2026-01-07 16,110 3,702 8.38%
2026-01-06 16,300 3,683 11.60%
2026-01-05 16,450 1,165 2.73%
2026-01-02 16,840 173 0.49%
2025-12-30 16,890 1,164 12.70%
2025-12-29 16,900 802 2.95%
2025-12-26 16,640 650 3.24%
2025-12-24 16,370 1,462 12.74%
2025-12-23 16,500 596 2.77%
2025-12-22 16,640 1,335 7.90%
2025-12-19 16,800 982 3.16%
2025-12-18 16,670 144 1.28%
2025-12-17 16,900 554 3.39%
2025-12-16 16,900 1,067 4.03%
2025-12-15 17,050 269 2.76%
2025-12-12 17,150 109 0.86%
2025-12-11 17,100 353 1.43%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2026-01-09 16,090 49,168 0.34%
2026-01-08 16,120 47,220 0.33%
2026-01-07 16,110 44,447 0.31%
2026-01-06 16,300 43,093 0.30%
2026-01-05 16,450 40,425 0.28%
2026-01-02 16,840 36,369 0.25%
2025-12-30 16,890 37,930 0.26%
2025-12-29 16,900 36,993 0.26%
2025-12-26 16,640 36,186 0.25%
2025-12-24 16,370 37,062 0.26%
2025-12-23 16,500 36,060 0.25%
2025-12-22 16,640 34,660 0.24%
2025-12-19 16,800 35,508 0.25%
2025-12-18 16,670 37,011 0.26%
2025-12-17 16,900 37,179 0.26%
2025-12-16 16,900 36,459 0.25%
2025-12-15 17,050 35,987 0.25%
2025-12-12 17,150 35,868 0.25%
2025-12-11 17,100 37,977 0.26%
2025-12-10 16,880 41,586 0.29%
2025-12-09 17,100 42,543 0.30%

λ””μ˜€ μ—…μ’… λ‚΄ 비ꡐ

의료μž₯λΉ„/μš©ν’ˆ μ—…μ’…(100개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© λ””μ˜€ μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 2,312.951 3,212.26 27μœ„
PER(졜근4λΆ„κΈ°) 39.163 -119.13 15μœ„
PBR 1.106 6.29 64μœ„
ROE(졜근4λΆ„κΈ°) -20.736 -34.16 63μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) -34.045 -120.9 64μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) -34.534 -163.16 58μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 68.205 127.87 33μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 1,196.499 737.56 18μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) -407.354 -11.41 97μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) -413.202 -48.78 90μœ„